News

Harbor Health’s funding was co-led by General Catalyst, 8VC and Alta Partners. The round also includes participation from Dell Family Office Management, Health 2047 Capital Partners, Lemhi Ventures, Martin Ventures and Breyer Capital. The post Harbor Health Secures $130M To Grow Insurance Plans and Clinical Footprint appeared first on MedCity News.

AllRock Bio’s drug is a small molecule pan-ROCK inhibitor ready for Phase 2 testing in pulmonary arterial hypertension and pulmonary hypertension with interstitial lung disease. The startup is led by the management team that steered CinCor Pharma to a $1.3 billion acquisition by AstraZeneca. The post With Drug Picked Up From Sanofi, Startup AllRock Takes […]

Healthcare, like baseball, is ultimately a human experience. And no matter how advanced the tools, patients still want to feel something real: that someone sees them, hears them, and cares. The post Humans Make the Game: What Baseball’s Tech Debate Can Teach Healthcare About the Value of Connection appeared first on MedCity News.

[Sponsored] Choosing the right brain injury rehabilitation program is a critical decision that can shape the future for you or your loved one. The post How (and Where) to Find the Best Value Rehabilitation Programs for Brain Injuries appeared first on MedCity News.

Addressing the obesity-cancer connection begins with awareness. The more we understand how excess weight influences cancer risk, the better equipped we are to intervene early, tailor treatment, and support long-term health. The post Obesity, Cancer, and the New Frontier of Treatment appeared first on MedCity News.

Berry Street’s new GLP-1 nutrition program supports patients who are starting GLP-1s, currently taking them or transitioning off of them. Patients receive care from registered dietitians and certified nutrition specialists. The post Berry Street Introduces GLP-1 Nutrition Program appeared first on MedCity News.

HBO’s The Pitt won three Emmys for its portrayal of the challenges faced by healthcare workers. Dr. Jason Cohen, a physician and chief medical officer of inpatient at patient flow automation startup Qventus, said the series highlights critical issues like emergency department boarding, staffing shortages and the mental toll on patient care and frontline staff. […]

[Sponsored] In this episode, a pharmacy benefit management executive and a pharmacy startup talk about why benefit verification, prior authorizations, and patient affordability still break the workflow and how smart integrations, real-time eligibility, and intuitive design can reduce friction for all involved. The post MedCity Pivot Podcast: Price Transparency is the New North in the […]

[Sponsored] Incorporating aquatic therapy can enhance patient outcomes and shorten recovery times for health care professionals. In the Chicago suburbs, the demand for such programs is rising. The post Discover the Most Effective Aquatic Therapy Programs in Chicago Suburbs appeared first on MedCity News.

Novartis is paying $120 million up front to secure rights to a Monte Rosa molecular glue degrader drug candidate as well as options for two others. The two companies began working together last year under an alliance focused on immune mediated-diseases. The post Novartis Adds to Its Immunology Prospects With Another Deal for Monte Rosa’s […]

Workers deserve environments that protect their well-being, and patients deserve care from professionals who aren’t operating in fear. The post Healthcare Leadership Strategies to Prevent Workplace Violence appeared first on MedCity News.

This isn’t a political issue, it’s a public health challenge with real consequences for kids’ futures. As reality sets in, we must face the possibility of a post-fluoridation era and find new ways to give kids in at-risk communities a fair shot at a healthy smile. The post Beyond Politics: Payer Solutions for Fluoride-free Communities […]

Walgreens has completed its sale to private equity firm Sycamore Partners, raising concerns that the deal could lead to widespread store closures, layoffs and reduced access to healthcare in vulnerable communities. The post What’s Next for Walgreens Following its Private Equity Sale? appeared first on MedCity News.

With positive Phase 1 results for the metabolic disorder drug MZE782, Maze Therapeutics plans to advance the small molecule to Phase 2 tests in phenylketonuria and chronic kidney disease. Following the data readout, Maze raised $150 million in a private placement. The post Maze Therapeutics Drug Shows Potential to Top Asset Acquired by Otsuka for […]

Healthcare groups are pushing back on CMS’ proposed physician fee schedule for next year, raising concerns over payment cuts, administrative burdens and mandatory participation in a new value-based model. Organizations including MGMA, NAACOS and Premier are calling on the agency to revise its plan. The post Industry Groups Warn CMS’ 2026 Fee Schedule Could Undermine […]

Putting aside the politics of this situation for the moment, here are some ways for commercial execs to navigate the current climate of volatility. The post How Pharma Marketers Can Prepare for Trump’s 200% Tariff Threat appeared first on MedCity News.

The longer we delay, the further we shift costs from polluters to patients — and to every taxpayer who funds Medicare, Medicaid and community hospitals. Environmental stewardship and human health are inseparable; regulating microplastics is preventive medicine on a national scale. The post Microplastics Are in Our Blood — Why Aren’t Federal Regulators Acting? appeared […]

Penguin Ai raised $29.7 million for its AI platform aimed at automating costly administrative tasks like prior authorization and medical coding. CEO Fawad Butt said the startup’s goal is to move beyond point solutions and create an “Epic of the healthcare back office.” The post Penguin Ai Snags $30M to Simplify Prior Auth, Coding and […]

Goodpath’s Series A round was led by MassMutual Ventures and included participation from Healthy Ventures. In total, the company has raised $22 million. The post Goodpath Rakes In $18M for Chronic Condition Platform appeared first on MedCity News.

Intercept Pharmaceuticals is voluntarily withdrawing from the market Ocaliva, a drug for the rare liver disease primary biliary cholangitis. While Ocaliva became an important new treatment option when it won accelerated FDA approval in 2016, PBC patients now have new FDA-approved medicines from Ipsen and Gilead Sciences that don’t pose the same safety risks. The […]